A recombinant platform for flavivirus vaccines and diagnostics using chimeras of a new insect-specific virus
Flaviviruses such as dengue, yellow fever, Zika, West Nile, and Japanese encephalitis virus present substantial global health burdens. New vaccines are being sought to address safety and manufacturing issues associated with current live attenuated vaccines. Here, we describe a new insect-specific fl...
Saved in:
Published in | Science translational medicine Vol. 11; no. 522 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
11.12.2019
|
Online Access | Get more information |
Cover
Loading…
Abstract | Flaviviruses such as dengue, yellow fever, Zika, West Nile, and Japanese encephalitis virus present substantial global health burdens. New vaccines are being sought to address safety and manufacturing issues associated with current live attenuated vaccines. Here, we describe a new insect-specific flavivirus, Binjari virus, which was found to be remarkably tolerant for exchange of its structural protein genes (prME) with those of the aforementioned pathogenic vertebrate-infecting flaviviruses (VIFs). Chimeric BinJ/VIF-prME viruses remained replication defective in vertebrate cells but replicated with high efficiency in mosquito cells. Cryo-electron microscopy and monoclonal antibody binding studies illustrated that the chimeric BinJ/VIF-prME virus particles were structurally and immunologically similar to their parental VIFs. Pilot manufacturing in C6/36 cells suggests that high yields can be reached up to 10
cell culture infectious dose/ml or ≈7 mg/liter. BinJ/VIF-prME viruses showed utility in diagnostic (microsphere immunoassays and ELISAs using panels of human and equine sera) and vaccine applications (illustrating protection against Zika virus challenge in murine IFNAR
mouse models). BinJ/VIF-prME viruses thus represent a versatile, noninfectious (for vertebrate cells), high-yield technology for generating chimeric flavivirus particles with low biocontainment requirements. |
---|---|
AbstractList | Flaviviruses such as dengue, yellow fever, Zika, West Nile, and Japanese encephalitis virus present substantial global health burdens. New vaccines are being sought to address safety and manufacturing issues associated with current live attenuated vaccines. Here, we describe a new insect-specific flavivirus, Binjari virus, which was found to be remarkably tolerant for exchange of its structural protein genes (prME) with those of the aforementioned pathogenic vertebrate-infecting flaviviruses (VIFs). Chimeric BinJ/VIF-prME viruses remained replication defective in vertebrate cells but replicated with high efficiency in mosquito cells. Cryo-electron microscopy and monoclonal antibody binding studies illustrated that the chimeric BinJ/VIF-prME virus particles were structurally and immunologically similar to their parental VIFs. Pilot manufacturing in C6/36 cells suggests that high yields can be reached up to 10
cell culture infectious dose/ml or ≈7 mg/liter. BinJ/VIF-prME viruses showed utility in diagnostic (microsphere immunoassays and ELISAs using panels of human and equine sera) and vaccine applications (illustrating protection against Zika virus challenge in murine IFNAR
mouse models). BinJ/VIF-prME viruses thus represent a versatile, noninfectious (for vertebrate cells), high-yield technology for generating chimeric flavivirus particles with low biocontainment requirements. |
Author | Warrilow, David Chow, Weng Kong Suhrbier, Andreas Hazlewood, Jessamine E Bielefeldt-Ohmann, Helle Harrison, Jessica J Watterson, Daniel Colmant, Agathe M G Hobson-Peters, Jody Kurucz, Nina Setoh, Yin Xiang Hall, Roy A Newton, Natalee D Piyasena, Thisun B H Finger, Mitchell Taylor, Carmel Yan, Kexin Vet, Laura J Khromykh, Alexander A Moore, Peter R Modhiran, Naphak Huang, Bixing Tang, Bing Nakayama, Eri Amarilla, Alberto A Young, Paul R Wheatley, Sarah |
Author_xml | – sequence: 1 givenname: Jody orcidid: 0000-0003-0139-9829 surname: Hobson-Peters fullname: Hobson-Peters, Jody email: roy.hall@uq.edu.au, j.peters2@uq.edu.au organization: Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Queensland, Australia. roy.hall@uq.edu.au j.peters2@uq.edu.au – sequence: 2 givenname: Jessica J orcidid: 0000-0002-3577-9910 surname: Harrison fullname: Harrison, Jessica J organization: Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Queensland, Australia – sequence: 3 givenname: Daniel orcidid: 0000-0001-5957-2853 surname: Watterson fullname: Watterson, Daniel organization: Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Queensland, Australia – sequence: 4 givenname: Jessamine E orcidid: 0000-0001-6104-4531 surname: Hazlewood fullname: Hazlewood, Jessamine E organization: Inflammation Biology Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia – sequence: 5 givenname: Laura J orcidid: 0000-0001-7587-2936 surname: Vet fullname: Vet, Laura J organization: Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Queensland, Australia – sequence: 6 givenname: Natalee D orcidid: 0000-0002-5617-8639 surname: Newton fullname: Newton, Natalee D organization: Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Queensland, Australia – sequence: 7 givenname: David orcidid: 0000-0002-3221-7605 surname: Warrilow fullname: Warrilow, David organization: Public Health Virology Laboratory, Department of Health, Queensland Government, PO Box 594, Archerfield, Queensland, Australia – sequence: 8 givenname: Agathe M G orcidid: 0000-0002-2004-4073 surname: Colmant fullname: Colmant, Agathe M G organization: Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Queensland, Australia – sequence: 9 givenname: Carmel surname: Taylor fullname: Taylor, Carmel organization: Public Health Virology Laboratory, Department of Health, Queensland Government, PO Box 594, Archerfield, Queensland, Australia – sequence: 10 givenname: Bixing orcidid: 0000-0002-7025-2292 surname: Huang fullname: Huang, Bixing organization: Public Health Virology Laboratory, Department of Health, Queensland Government, PO Box 594, Archerfield, Queensland, Australia – sequence: 11 givenname: Thisun B H orcidid: 0000-0002-1657-8558 surname: Piyasena fullname: Piyasena, Thisun B H organization: Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Queensland, Australia – sequence: 12 givenname: Weng Kong orcidid: 0000-0003-3609-2499 surname: Chow fullname: Chow, Weng Kong organization: Australian Defence Force Malaria and Infectious Disease Institute, Gallipoli Barracks, Queensland, Australia – sequence: 13 givenname: Yin Xiang orcidid: 0000-0002-1683-3555 surname: Setoh fullname: Setoh, Yin Xiang organization: Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Queensland, Australia – sequence: 14 givenname: Bing orcidid: 0000-0003-0281-2160 surname: Tang fullname: Tang, Bing organization: Inflammation Biology Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia – sequence: 15 givenname: Eri orcidid: 0000-0002-0826-3513 surname: Nakayama fullname: Nakayama, Eri organization: Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 16 givenname: Kexin orcidid: 0000-0003-2203-217X surname: Yan fullname: Yan, Kexin organization: Inflammation Biology Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia – sequence: 17 givenname: Alberto A orcidid: 0000-0002-6640-3377 surname: Amarilla fullname: Amarilla, Alberto A organization: Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Queensland, Australia – sequence: 18 givenname: Sarah surname: Wheatley fullname: Wheatley, Sarah organization: Public Health Virology Laboratory, Department of Health, Queensland Government, PO Box 594, Archerfield, Queensland, Australia – sequence: 19 givenname: Peter R surname: Moore fullname: Moore, Peter R organization: Public Health Virology Laboratory, Department of Health, Queensland Government, PO Box 594, Archerfield, Queensland, Australia – sequence: 20 givenname: Mitchell orcidid: 0000-0002-3861-1443 surname: Finger fullname: Finger, Mitchell organization: Public Health Virology Laboratory, Department of Health, Queensland Government, PO Box 594, Archerfield, Queensland, Australia – sequence: 21 givenname: Nina surname: Kurucz fullname: Kurucz, Nina organization: Centre for Disease Control, Health Protection Division, Northern Territory Department of Health, Darwin, Northern Territory, Australia – sequence: 22 givenname: Naphak orcidid: 0000-0003-3205-4970 surname: Modhiran fullname: Modhiran, Naphak organization: Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Queensland, Australia – sequence: 23 givenname: Paul R surname: Young fullname: Young, Paul R organization: Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Queensland, Australia – sequence: 24 givenname: Alexander A surname: Khromykh fullname: Khromykh, Alexander A organization: Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Queensland, Australia – sequence: 25 givenname: Helle surname: Bielefeldt-Ohmann fullname: Bielefeldt-Ohmann, Helle organization: School of Veterinary Science, University of Queensland Gatton Campus, Queensland 4343, Australia – sequence: 26 givenname: Andreas surname: Suhrbier fullname: Suhrbier, Andreas organization: Inflammation Biology Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia – sequence: 27 givenname: Roy A orcidid: 0000-0001-5778-1387 surname: Hall fullname: Hall, Roy A email: roy.hall@uq.edu.au, j.peters2@uq.edu.au organization: Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Queensland, Australia. roy.hall@uq.edu.au j.peters2@uq.edu.au |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31826984$$D View this record in MEDLINE/PubMed |
BookMark | eNo1kMtKAzEYRoMo9qJvIJIXmJqkmVyWpWgVCm50Xf75k9TITGZIplXf3uJlc77dge_MyHnqkyfkhrMF50LdFYxjhlTazrsFwKc2xpyRKbdSVUpIMSGzUt4ZU2ZZq0syWXIjlDVyStoVzR77rokJ0kiHFsbQ546eQEMLx3iM-VDoERBj8oVCctRF2Ke-jBELPZSY9hTfYuczFNoHCjT5DxpT8ThWZfAYQ0T6o7kiFwHa4q__dk5eH-5f1o_V9nnztF5tK5SMj5Vx2jFuvXTaKykbUTPglgWmuNLWBGsa1nhXo6hRW854zRsNAq3RVtSAYk5uf73DoTkV2Q05dpC_dv-3xTe8wV8a |
CitedBy_id | crossref_primary_10_1038_s41541_022_00503_y crossref_primary_10_1099_jgv_0_001617 crossref_primary_10_3390_biologics4010001 crossref_primary_10_3389_fimmu_2020_01817 crossref_primary_10_1016_j_virol_2021_07_004 crossref_primary_10_1038_s41467_021_23779_5 crossref_primary_10_1016_j_pathol_2022_07_001 crossref_primary_10_1002_eji_202250133 crossref_primary_10_3390_vaccines11071250 crossref_primary_10_1126_sciadv_add8095 crossref_primary_10_3390_v14040792 crossref_primary_10_3390_v14071501 crossref_primary_10_1016_j_virol_2022_07_013 crossref_primary_10_1038_s41467_021_22773_1 crossref_primary_10_1128_mSphere_00095_20 crossref_primary_10_3390_v14061298 crossref_primary_10_1016_j_onehlt_2023_100565 crossref_primary_10_1038_s41541_023_00688_w crossref_primary_10_1016_j_bbrc_2022_05_080 crossref_primary_10_3390_insects14020166 crossref_primary_10_1128_jvi_01638_23 crossref_primary_10_3390_v12060621 crossref_primary_10_3390_pathogens9070589 crossref_primary_10_1371_journal_ppat_1009788 crossref_primary_10_1128_spectrum_02796_22 crossref_primary_10_1038_s41541_021_00328_1 crossref_primary_10_1126_sciadv_abe4507 crossref_primary_10_1371_journal_pbio_3001201 crossref_primary_10_1099_jgv_0_001991 crossref_primary_10_3390_v14051106 crossref_primary_10_1038_s41577_024_01016_6 crossref_primary_10_1099_jgv_0_001518 crossref_primary_10_3390_v14122759 crossref_primary_10_3390_vaccines9030263 crossref_primary_10_1128_mbio_01388_23 crossref_primary_10_1371_journal_ppat_1009215 crossref_primary_10_3390_v15010139 crossref_primary_10_1038_s41467_022_35407_x crossref_primary_10_3390_vaccines9111230 crossref_primary_10_1038_s41467_022_28977_3 crossref_primary_10_1016_j_virol_2021_03_014 crossref_primary_10_3390_vaccines8030496 crossref_primary_10_3390_vaccines9101142 crossref_primary_10_1128_aem_01062_22 crossref_primary_10_3389_fmicb_2022_997058 crossref_primary_10_3390_v15051113 crossref_primary_10_3390_vaccines9030273 crossref_primary_10_3390_v13091807 crossref_primary_10_3390_vaccines8020258 crossref_primary_10_1038_s44298_024_00025_5 crossref_primary_10_3390_vaccines10010085 crossref_primary_10_1126_science_abb9425 crossref_primary_10_1128_jvi_01251_23 crossref_primary_10_3390_v13091843 crossref_primary_10_1099_jgv_0_001647 crossref_primary_10_1093_infdis_jiad238 crossref_primary_10_1016_j_pt_2023_11_002 crossref_primary_10_1016_j_coviro_2020_05_002 crossref_primary_10_3390_vaccines8030368 crossref_primary_10_1007_s00253_023_12817_5 crossref_primary_10_3390_v12091056 crossref_primary_10_3390_v13040573 crossref_primary_10_1111_pbi_14152 |
ContentType | Journal Article |
Copyright | Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. |
Copyright_xml | – notice: Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. |
DBID | NPM |
DOI | 10.1126/scitranslmed.aax7888 |
DatabaseName | PubMed |
DatabaseTitle | PubMed |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1946-6242 |
ExternalDocumentID | 31826984 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 0R~ 4.4 53G 7~K ABJNI ACGFS AENEX AJGZS AJWWR ALMA_UNASSIGNED_HOLDINGS BKF C45 DU5 EBS EMOBN F5P HZ~ NPM O9- OFXIZ OVD OVIDX P2P RHI TEORI |
ID | FETCH-LOGICAL-c401t-8d7d019e4d7e644b250a190f0616798f98b0bed5c25c7910151b7a2c987925ac2 |
IngestDate | Thu May 23 23:44:05 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 522 |
Language | English |
License | Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c401t-8d7d019e4d7e644b250a190f0616798f98b0bed5c25c7910151b7a2c987925ac2 |
ORCID | 0000-0003-2203-217X 0000-0002-5617-8639 0000-0002-0826-3513 0000-0002-2004-4073 0000-0001-7587-2936 0000-0003-3205-4970 0000-0003-3609-2499 0000-0001-6104-4531 0000-0002-1657-8558 0000-0002-3221-7605 0000-0003-0139-9829 0000-0001-5957-2853 0000-0002-1683-3555 0000-0003-0281-2160 0000-0002-3577-9910 0000-0002-6640-3377 0000-0001-5778-1387 0000-0002-3861-1443 0000-0002-7025-2292 |
PMID | 31826984 |
ParticipantIDs | pubmed_primary_31826984 |
PublicationCentury | 2000 |
PublicationDate | 2019-12-11 |
PublicationDateYYYYMMDD | 2019-12-11 |
PublicationDate_xml | – month: 12 year: 2019 text: 2019-12-11 day: 11 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Science translational medicine |
PublicationTitleAlternate | Sci Transl Med |
PublicationYear | 2019 |
SSID | ssj0068356 |
Score | 2.5762439 |
Snippet | Flaviviruses such as dengue, yellow fever, Zika, West Nile, and Japanese encephalitis virus present substantial global health burdens. New vaccines are being... |
SourceID | pubmed |
SourceType | Index Database |
Title | A recombinant platform for flavivirus vaccines and diagnostics using chimeras of a new insect-specific virus |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31826984 |
Volume | 11 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9tAEF2FIiEuFZS2FEq1B26RUWyvvfYxQkFRJTiB4Ib2U42UD0ScqOX38EOZ2fXWJikIellF3nhl-z2P3-zO7BByHGubqlIxQCAHByVP40hwriMGQo4lIo1zt9B-fpEPr9jPm-ym03lsRS0tKnmiHv6ZV_I_qMIxwBWzZN-B7N9B4QD8BnyhBYShfRPG_S76sxPpolmwIHSFEtRFDtqxWI6Wo_vFvLsUClfP_WbM2ofWuc2ZFz7j9tcIJ6bmPlMSVDbGp4MZjDAJEwOJum6YtooNBqHCD904TCeuLtMPZ1ibPHIRwPVqg_7TWLx7V_3QR9jMkSvNCtW13_TT9_ok-Oa8h7EJcUJ4opigTh60Zy9iV3qhtq7GW9yS5REmqTwzyXGLeplPXF639aE6pb9ZuMkTIX6jS9_-OyB2N3H4p-hKlb4g3eu9Kztwh64NssELLA9ygTNC_mufg4LN65TMOhlr7XK2yVYYYsV5cSLmcod8rL0P2vdU2iUdM_1Ets5r4PbIuE9bjKKBURQa2jCKBkZRYBRtMYo6RtHAKDqzVFBgFF1hFHXDfCZXZ4PL02FU1-OIFHjhVVRorgFCwzQ3IKMlqGcBetLCW45rebYsZE8anakkUxxkKIhJyUWiyoKXSSZU8oV8mM6mZp9Qy3jGRGGMtJYVKhW6SDHQo1eKHssz-Y189c_p9s5vunIbnuDBiz2HZLth2HeyaeEtN0cgGSv5w2H2BNXZdB0 |
link.rule.ids | 780 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+recombinant+platform+for+flavivirus+vaccines+and+diagnostics+using+chimeras+of+a+new+insect-specific+virus&rft.jtitle=Science+translational+medicine&rft.au=Hobson-Peters%2C+Jody&rft.au=Harrison%2C+Jessica+J&rft.au=Watterson%2C+Daniel&rft.au=Hazlewood%2C+Jessamine+E&rft.date=2019-12-11&rft.eissn=1946-6242&rft.volume=11&rft.issue=522&rft_id=info:doi/10.1126%2Fscitranslmed.aax7888&rft_id=info%3Apmid%2F31826984&rft_id=info%3Apmid%2F31826984&rft.externalDocID=31826984 |